Idorsia Ltd (OTCMKTS:IDRSF) Short Interest Update

Idorsia Ltd (OTCMKTS:IDRSF) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 3,760,300 shares, a decline of 28.3% from the February 28th total of 5,248,000 shares. Based on an average daily volume of 300 shares, the short-interest ratio is currently 12,534.3 days.

Idorsia Stock Performance

Idorsia stock remained flat at $1.05 during mid-day trading on Monday. Idorsia has a 1-year low of $0.70 and a 1-year high of $2.88. The firm has a 50 day moving average price of $1.00 and a two-hundred day moving average price of $1.33.

Idorsia Company Profile

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.